Delivery Order SPE2DB24D1205-SPE2DB24FCQRT

Award Date 4/19/24
Potential Completion Date 4/22/24
Potential Value $57K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $11,537.80 firm-fixed price Delivery Order contract to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of ENBREL 50 MG/ML syringes and has a completion date of September 5, 2024. AmerisourceBergen is a major pharmaceutical distributor that provides a wide range of essential medical commodities to various federal agencies, including the military. This contract award is part of AmerisourceBergen's...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a $42,222.47 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division to provide 4,565,425,768 milliliters of the biologic drug ENBREL 50 mg/ml syringes. The contract has an ultimate completion date of August 13, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) Amerisourcebergen holds with the DLA, valued up to $999,999,999 through December 2025, for...
This $80,202.14 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of ENBREL 50 MG/ML SYRINGEML pharmaceutical products. The award has an ultimate completion date of April 17, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a wide range of medications and medical supplies...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $19,410.24 firm-fixed-price contract is for the supply of ENBREL 50 MG/ML SURECLICK, a specialty medication. The delivery order has an ultimate completion date of October 2, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ENBREL 50 MG/ML syringes. The contract has a potential value of $9,301.30 and a performance period through March 5, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed-price delivery order contract (SPE2DX15D3005|SPE2DX24F3QEA) valued at $49,858.19 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ENBREL 50 MG/ML syringes. The contract has an ultimate completion date of March 19, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, is the prime contractor on this order and has also received an indefinite delivery...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $43,105.79 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, which has no set-aside designation, is for the delivery of ENBREL 50 MG/ML SURECLICKML pharmaceutical products. Amerisourcebergen Drug Corp is the prime contractor and is the recipient of a single-award indefinite delivery contract (IDC) from DLA valued up to...
The U.S. government agency Defense Logistics Agency (DLA) Troop Support Medical awarded a $17,097.31 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $99,348.69 firm fixed-price delivery order contract covers the supply of ENBREL 50 MG/ML SYRINGEML, a specialty medication. The contract has an ultimate completion date of January 22, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $7,869.98, is for the delivery of ENBREL 50 MG/ML syringes. The contract is a firm-fixed-price delivery order with a completion date of June 3, 2024. The contract is not designated as a set-aside award. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB24FCQRT
    Delivery Order

The U.S. Defense Logistics Agency (DLA) has awarded a Delivery Order contract, valued at $57,321.41, to Amerisourcebergen Drug Corporation's Corporate Office division. This contract is for the supply of ENBREL 50 MG/ML syringes, with an ultimate completion date of April 22, 2024. The contract is a Firm Fixed Price arrangement, without any set-aside designation.

Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000.

Generated 7/19/24, 9:52 AM